Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Cardiovascular disease: identifying and supporting people most at risk of dying early

Public health guideline
Reference number: PH15
Published: 24 September 2008

Register as a stakeholder

History

Surveillance consultation

Surveillance consultation
Comments form (MSWord 26 KB)

Published:

12 April 2018
Surveillance review proposal (PDF 807 KB)

Published:

12 April 2018

Stakeholder list updated

Stakeholder list (PDF 160 KB)

Published:

10 April 2018

Review documents

Review 1 - 2014
Review decision (PDF 85 KB)

Published:

24 October 2011
Response table (PDF 394 KB)

Published:

13 February 2014
Review proposal consultation information
Review proposal consultation document (PDF 48 KB)

Published:

01 November 2013

Final fieldwork report

Final fieldwork report (PDF 347 KB)

Published:

25 September 2008

PHIAC minutes

PHIAC minutes
Minutes of the meeting held on 14 March 2008 (PDF 62 KB)

Published:

06 December 2013
Minutes of the meeting held on 16 November 2007 (PDF 78 KB)

Published:

24 January 2008

List of registered stakeholders

List of registered stakeholders (PDF 41 KB)

Published:

05 August 2008

Consultation on the additional evidence

Consultation on the additional evidence information
Consultation on the additional evidence: supplementary economic analysis on interventions to reduce health inequalities (PDF 187 KB)

Published:

17 September 2008

Services in disadvantaged areas: stakeholder comments and response table on the evidence

Services in disadvantaged areas: final scope (PDF 57 KB)

Published:

29 June 2007

Consultation on the draft guidance

Consultation on the draft guidance information
Guidance consultation comments response table (PDF 403 KB)

Published:

07 May 2015
Evidence consultation comments response table (PDF 46 KB)

Published:

07 May 2015
Proactive case finding and retention and improving access to services in disadvantaged areas - draft guidance (PDF 217 KB)

Published:

23 April 2008

Services in disadvantaged areas - consultation on the summary of evidence

Services in disadvantaged areas - consultation on the summary of evidence information
Background documents
Services in disadvantaged areas: Mapping review (PDF 646 KB)

Published:

27 September 2007
Services in disadvantaged areas: Mapping review - Appendix 8 (PDF 486 KB)

Published:

27 September 2007
Services in disadvantaged areas: Smoking review (PDF 352 KB)

Published:

27 September 2007
Services in disadvantaged areas: Statins report (PDF 285 KB)

Published:

27 September 2007
Services in disadvantaged areas: Statins report (Appendix A) (PDF 322 KB)

Published:

27 September 2007
Services in disadvantaged areas: Statins report (Appendix B) (PDF 128 KB)

Published:

27 September 2007
Services in disadvantaged areas: Statins report (Appendix C) (PDF 243 KB)

Published:

27 September 2007
Services in disadvantaged areas: Health economic effectiveness review (PDF 964 KB)

Published:

27 September 2007
Consultation documents
Services in disadvantaged areas: Introduction to the consultation on the draft summary of evidence (PDF 28 KB)

Published:

27 September 2007
Services in disadvantaged areas: Evidence Summary - Mapping (PDF 46 KB)

Published:

27 September 2007
Services in disadvantaged areas: Evidence Summary - Smoking Cessation (PDF 58 KB)

Published:

27 September 2007
Services in disadvantaged areas: Evidence Summary - Statins (PDF 71 KB)

Published:

27 September 2007
Services in disadvantaged areas: Evidence Summary - Health Economics (PDF 38 KB)

Published:

27 September 2007
Services in disadvantaged areas - Stakeholder Comments Form (MSWord 56 KB)

Published:

27 September 2007

Services in disadvantaged areas: final scope

Services in disadvantaged areas: final scope (PDF 57 KB)

Published:

29 June 2007

Services in disadvantaged areas: draft scope - Stakeholder response table

Services in disadvantaged areas: draft scope - Stakeholder response table (PDF 775 KB)

Published:

29 June 2007

Services in disadvantaged areas: draft scope

Services in disadvantaged areas: draft scope (PDF 40 KB)

Published:

29 January 2007

Services in disadvantaged areas: attendance form for stakeholder meeting on 8 February 2007

Services in disadvantaged areas: attendance form for stakeholder meeting on 8 February 2007 (MSWord 35 KB)

Published:

28 December 2006